Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. (Q39500813)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. |
scientific article |
Statements
Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study (English)
Koya Ariyoshi
Konosuke Morimoto
Bhim Gopal Dhoubhadel
Tomoko Ishifuji
Michio Yasunami
Makito Yaegashi
Norichika Asoh
Masayuki Ishida
Sugihiro Hamaguchi
Masahiro Aoshima
Adult Pneumonia Study Group-Japan (APSG-J)